Oxidative Stress and the Free Radical Theory

Denham Harman proposed the free radical theory of aging in 1956: mitochondria generate reactive oxygen species (ROS) as a byproduct of energy production, and cumulative oxidative damage to DNA, proteins, and lipids drives aging. For decades this was one of the field's dominant explanatory frameworks, and it motivated a wave of consumer antioxidant supplementation (vitamin E, vitamin C, beta-carotene) marketed on longevity claims [1].

The theory's predictive record in controlled human trials has been poor. A 2012 large meta-analysis and several subsequent Cochrane reviews of antioxidant supplement RCTs found no reduction in all-cause mortality from vitamin E, vitamin C, or beta-carotene supplementation, and beta-carotene supplementation was associated with increased lung cancer risk and increased mortality in smokers in two large trials (ATBC and CARET) [2]. Mouse studies overexpressing antioxidant enzymes (catalase, superoxide dismutase) have shown mixed lifespan effects, extending lifespan in some strains and tissues but not reliably across the board, undermining a simple linear more-antioxidant-capacity-equals-longer-life model [1].

What the evidence does not show: ROS are not simply damaging waste; they also function as essential signaling molecules that trigger protective adaptive responses (a concept called mitohormesis), meaning that blunting ROS entirely with high-dose antioxidant supplementation can blunt beneficial exercise adaptations, a finding replicated in several human exercise physiology trials where vitamin C and E supplementation reduced training-induced improvements in insulin sensitivity and mitochondrial biogenesis [3]. This directly undercuts the assumption that more antioxidants is always better.

Blueprint's protocol does not include high-dose antioxidant vitamin supplementation as a core strategy for this reason; Bryan Johnson's stack emphasizes measured micronutrient sufficiency and NAD-pathway support rather than mega-dosing classic antioxidant vitamins, consistent with the mitohormesis-informed shift away from blanket antioxidant supplementation [4].

Critics, including researchers who study mitochondrial signaling, argue the free radical theory in its original strong form (ROS as the primary, sufficient driver of aging) has been effectively falsified by the antioxidant trial failures and the mitohormesis findings, even though oxidative damage remains a real, measurable contributor to specific pathologies like atherosclerosis and some cancers [2][3]. Commentary from McGill researchers reviewing this literature explicitly cautioned against the simplified public narrative that free radicals are uniformly harmful and antioxidants uniformly protective, arguing the signaling role of ROS deserved more attention in how the theory was being communicated [5]. The original ATBC trial itself, one of the two large beta-carotene studies showing harm in smokers, remains a frequently cited cautionary example of a plausible mechanistic hypothesis failing, and actively backfiring, in a rigorous RCT [6].

The plain takeaway: oxidative damage happens and matters for specific diseases, but broadly suppressing it with antioxidant supplements has not been shown to extend human lifespan and may blunt some of the benefits of exercise.